Drosophila models pioneer a new approach to drug discovery for Parkinson's disease
- 1 February 2006
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 11 (3-4) , 119-126
- https://doi.org/10.1016/s1359-6446(05)03693-7
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Molecular Pathogenesis of Parkinson DiseaseArchives of Neurology, 2005
- Pharmacological prevention of Parkinson disease in DrosophilaNature Medicine, 2002
- Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's DiseaseScience, 2002
- Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's DiseaseScience, 2001
- Comparative Genomics of the EukaryotesScience, 2000
- A Drosophila model of Parkinson's diseaseNature, 2000
- Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70Nature Genetics, 1999
- Mutations in the parkin gene cause autosomal recessive juvenile parkinsonismNature, 1998
- α-Synuclein in Lewy bodiesNature, 1997
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997